Literature DB >> 1460095

Microglial cell upregulation of HIV-1 expression in the chronically infected promonocytic cell line U1: the role of tumor necrosis factor-alpha.

P K Peterson1, G Gekker, S Hu, Y Schoolov, H H Balfour, C C Chao.   

Abstract

Culture supernatants from lipopolysaccharide (LPS)-treated murine microglial cells were found to markedly induce the expression of human immunodeficiency virus (HIV)-1 in the chronically infected human promonocytic cell line U1 as detected by measurements of HIV-1 p24 antigen release into U1 culture supernatants. Antibody to tumor necrosis factor (TNF)-alpha had an inhibitory effect on the induction of virus by microglial cell supernatants. Also, treatment of microglia with pentoxifylline, an inhibitor of TNF-alpha production, resulted in suppressed amounts of TNF in the supernatants of LPS-treated microglia and in a reduced stimulatory capacity of these supernatants on HIV-1 expression in U1 cells. These findings support the concept that TNF-alpha production by glial cells plays a pathogenetic role in HIV-1-associated brain disease by promoting the expression of the virus in infected cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460095     DOI: 10.1016/0165-5728(92)90198-t

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  4 in total

Review 1.  Neuropsychiatric manifestations of HIV infection and AIDS.

Authors:  Benoit Dubé; Tami Benton; Dean G Cruess; Dwight L Evans
Journal:  J Psychiatry Neurosci       Date:  2005-07       Impact factor: 6.186

2.  Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro.

Authors:  W S Sheng; S Hu; F H Kravitz; P K Peterson; C C Chao
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

3.  Thalidomide inhibits lipoarabinomannan-induced upregulation of human immunodeficiency virus expression.

Authors:  P K Peterson; G Gekker; M Bornemann; D Chatterjee; C C Chao
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 4.  Opioid and neuroHIV Comorbidity - Current and Future Perspectives.

Authors:  Sylvia Fitting; MaryPeace McRae; Kurt F Hauser
Journal:  J Neuroimmune Pharmacol       Date:  2020-09-02       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.